# XENON PHARMACEUTICALS INC. (XENE) FY2026 Q2 Balance Sheet

- Company: XENON PHARMACEUTICALS INC. (XENE)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001193125-26-338244
- Page: https://plicit.ai/financials/xene/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/xene-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 1,295,772,000 US dollars
- **Current assets**: 945,868,000 US dollars
- **Non-current assets**: 349,904,000 US dollars
- **Liabilities**: 53,376,000 US dollars
- **Current liabilities**: 45,009,000 US dollars
- **Non-current liabilities**: 8,367,000 US dollars
- **Equity**: 1,242,396,000 US dollars
- **Marketable securities (note 5)**: 811,159,000 US dollars
- **Cash and cash equivalents**: 119,527,000 US dollars
- **Prepaid expenses and other current assets**: 13,553,000 US dollars
- **Other receivables**: 1,629,000 US dollars
- **Marketable securities, long-term (note 5)**: 314,411,000 US dollars
- **Deferred tax assets**: 14,361,000 US dollars
- **Prepaid expenses, long-term**: 7,973,000 US dollars
- **Property, plant and equipment, net**: 7,774,000 US dollars
- **Operating lease right-of-use asset, net (note 6)**: 5,385,000 US dollars
- **Accounts payable and accrued liabilities (note 7)**: 43,671,000 US dollars
- **Operating lease liability (note 6)**: 1,338,000 US dollars
- **Operating lease liability, long-term (note 6)**: 5,080,000 US dollars
- **Other liabilities, long-term**: 3,287,000 US dollars
- **Common shares, without par value; unlimited shares authorized; issued and outstanding: 96,752,884 (December 31, 2025 - 80,010,790) (note 8)**: 2,426,619,000 US dollars
- **Additional paid-in capital**: 276,851,000 US dollars
- **Accumulated deficit**: negative 1,458,418,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 2,656,000 US dollars
- **Gross equity (calculated)**: 2,703,470,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.